What is pathophysiology of Alzheimer?

['Ascolta questa pagina']

Cos'è la fisiopatologia de l'Alzheimer?

La fisiopatologia de la malatia de Alzheimer (MA) l"è un process cumpless qe l"implica l'accumulazion de proteine anormali, l'infiammazion e la disfunzion neuronal.

I du carateristich principai de l'AD sun la presenza de placche beta-amiloide (Aβ) e grovigli neurofibrillari (NFT) in del cervel.

I plach beta-amiloide se forman quand i framm de la proteina precursora amiloide (APP) inn scis per i enzimi per formar i peptidi Aβ.

Chesti peptidi se aggregen e formen fibrille insolubil qe se accumulen fœra dei neuron, interrompen la comunicazion de cellula a cellula e condusen a la mort neuronal.

L'accumulament de placche Aβ l"è credud de vess vun di primm events in del desvilup de l'AD, e se cred de contribuir al process neurodegenerativ.

I grovigli neurofibrillari se forman quand la proteina tau la ven iperfosforilada e la forma filament anormai ind i neuron.

Chesti grovigli disturben el funzionament normal dei microtubuli, che sun essenzial per el trasport di nutrient e olter material denter del neurun.

I grov i pœl portar a la mort dei neuron infettads.

L'infiammaziun la g'ha anca un rœl ind la fisiopatologia de l'AD.

El sistema immunitari el risponde a l'accumulazion de placche Aβ e NFT liberand citochine pro-inflamatorie, qe pœden aggravar el danno ai neuron.

Inoltra, g'è di evidenz qe el stress ossidativ, la disfunzion mitocondriala e el metabolism del glucosio indebolì contribuissen a la fisiopatologia de l'AD.

Chesti fattur pœden portar a una disfunzion e a la mort neuronal, aggravand ulterament el process de la malatia.

In general, la fisiopatologia de l'AD l"è una interazion cumplessa de fattur multiples qe in fin dei conti i porta a la diminuzion progressiva de la funzion cognitiva e a la perdita de memoria qe caratterisa la malatia.

['Referenz']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['Disclaimer: medegh']

['Chestu sit web l"è furnid dumà per scopi educatif e informativ e l"è minga un cunsigli medich o un servizzi prufessiunal.']

["I informaziun furnid i g'han minga de vess drovad per diagnosticar o curar un prublema de salute o una malatia, e quei qe i cercan un cunsili medegh personal i g'han de consultar un medegh licenziad."]

['Per piasè, tegnì cont che la red neural che la genera rispost ai dumand l"è minga precisa quand che se tratta de numer, per esempi, el numer de gent che g\'ha una malattia precisa.']

["Cercà semper el cunsili del tò dutur o de un olter fornitur de sanità qualificaa in su una cundizion medica. Mai ignorà el cunsili medich prufessional o ritardà in de cercàll per via de un quaicoss che te gh'heet legiu in su'sto sit web. Se te penset de avègh una emergenza medica, ciama el 911 o va in del pronto soccors püssee vesin subit."]

['Disclaimer: copyright']

["El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà recurs ai proprietari de copyright che creden che el material che 'l compariss in su Internet el infrange i sò dirit sota la legg di copyright di Stat Ünì. "]

["Se te credet de bona fede che un qualcun contegnü o material metüü a disposiziun in cunnessión cun el noster sit web o i noster servizzi infrang el tò copyright, te (o el tò agent) pudet mandà un avisi che dumanda che el contegnü o material vegn tolt, o che l'access a lü el vegn blocaa."]

['I avisi i g\'ha de vess mandaa per scrit per email (varda la sezion "Cuntatt" per l\'indirizz email).']

["La DMCA la dis che la tua notifica de presunta violazion del copyright la gh'ha de cuntà la seguent informazion: (1) descrizion de l'opera protetta dal copyright che l'è oget de la presunta violazion; (2) descrizion del presunt contegnud che 'l viola e informazion suficent per permetem de localizà el contegnud; (3) informazion de contatt per ti, cumprend el to indirizz, numer de telefon e indirizz email; (4) una declarazion de ti che te gh'heet bona fede che 'l contegnud de la manera reclamada l'è minga autorizzaa del proprietari del copyright, o del sò agent, o de la funzion de nissuna legg; "]

['(5) una declaraziun de ti, firmada sota pena de spergiur, che l\'informaziun in de la notificaziun l"è precisa e che te gh\'heet l\'autorità per fà valer i dirit de autor che se pretend de vess violaa;']

['e (6) una firma fisica o eletronica del proprietari del copyright o de una persona autorizada a agì per el proprietari del copyright.']

['Se no se inclüden tücc i infurmaziun sura indicà pœden causà un ritard in del processà la tua denuncia.']

['cuntatt']

['Per piasè mandem una mail cun qual-sa-vöör dumanda/suggeriment.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.